Axonics, Medtronic
Axonics defeats Medtronic lawsuit in spine-stimulation patent trial
Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology.
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run afoul of three patents held by the company’s main rival, Medt | The case is one of several intellectual property disputes between the medtech giant and Axonics—which is currently waiting to become a subsidiary of Boston Scientific.
Axonics gains after win in trial in patent dispute with Medtronic
Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in is favor in a patent dispute with Medtronic (MDT). Medtronic (MDT) was seeking $150 million in a patent dispute with Axonics (AXNX),
Jury sides with Axonics in Medtronic patent dispute
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
Jury Finds Axonics Did Not Infringe Any of Three Patents-in-Suit
A jury unanimously found that Axonics did not infringe any of the three patents-in-suit brought against the company by Medtronic in a patent infringement lawsuit in the U.S. District Court for the Central District of California.
Axonics did not infringe Medtronic’s patents, jury rules
The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s patents with its r-SNM devices.
Medtronic PLC stock outperforms competitors on strong trading day
Medtronic PLC closed $1.63 below its 52-week high ($91.49), which the company achieved on September 4th.
Medtronic Unusual Options Activity For September 23
Earnings announcement expected in 57 days. 20-year pro options trader reveals his one-line chart technique that shows when to ...
The past three years for Medtronic (NYSE:MDT) investors has not been profitable
While it may not be enough for some shareholders, we think it is good to see the Medtronic plc ( NYSE:MDT ) share ...
Becker's Spine Review1h
eCential Robotics adds former Medtronic, Zimmer Biomet leaders
Lisa Jacobs and Matthieu Ville have been tapped to serve on the leadership team of eCential Robotics.
Medtronic PLC stock outperforms competitors despite losses on the day
Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.
Medtronic Buy Rating Affirmed: Sustained Growth and Strong Pipeline Drive Positive Outlook
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...
Medtronic: An Undervalued Stock With Durable Competitive Advantages
Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...
3 Reasons Medtronic's Stock Can Continue Rallying Higher
Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...
Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership
"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...